BIOFILCHEM — Biofil Chemicals and Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹815.97m
- IN₹818.13m
- IN₹334.02m
Annual cashflow statement for Biofil Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 19.2 | 10.1 | 7.93 | 8.65 | 7.36 |
| Depreciation | |||||
| Non-Cash Items | 0.727 | 0.507 | -0.541 | 2.34 | 0.579 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -12.9 | -17.1 | -12.8 | 8.95 | -31 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11.1 | -2.2 | -1.12 | 23.9 | -19.2 |
| Capital Expenditures | -5.67 | -0.699 | -0.106 | -0.229 | -1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.71 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.961 | -0.699 | -0.106 | -0.229 | -1 |
| Financing Cash Flow Items | -0.681 | -0.406 | -0.425 | -0.415 | -0.369 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -8.3 | -0.058 | 0.151 | -1.25 | -0.045 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.84 | -2.96 | -1.07 | 22.5 | -20.3 |